PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Alzheimer's vaccine trial aims to slow memory loss
Disease control Not yet recruitingThis study is testing whether a vaccine called AADvac1 can slow the progression of Alzheimer's disease in its earliest stages. It will involve 375 adults aged 50-80 who have very early signs of the disease. The vaccine targets a protein called tau, and researchers will see if it …
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope in fight against Alzheimer's: Dual-Attack drug trial launches
Disease control Not yet recruitingThis clinical trial aims to test whether new drugs that target tau protein in the brain can slow Alzheimer's disease progression, either alone or combined with existing amyloid-targeting treatments. It will enroll 750 adults aged 50-80 who have early signs of Alzheimer's but mini…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
First human test of Alzheimer's prevention vaccine begins
Prevention Not yet recruitingThis early-stage study aims to test the safety of an experimental vaccine called AV-1980R in older adults who show early biological signs of Alzheimer's disease but don't yet have memory problems. The study will enroll 48 participants aged 65-80 who will receive either the vaccin…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE1 • Sponsor: Institute for Molecular Medicine • Aim: Prevention
Last updated Apr 02, 2026 14:56 UTC